Watson Pharmaceuticals Inc. (NYSE:WPI) recently announced that it has reached a settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson (NYSE:JNJ), on a patent litigation related to Watson Pharma’s generic version of Janssen’s birth control pill, Ortho Tri-Cyclen Lo.
According to the settlement agreement, Janssen will manufacture and supply an authorized generic version of Ortho Tri-Cyclen Lo to Watson Pharma, which will in turn market and distribute the authorized … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards